Harpoon Therapeutics Inc
Change company Symbol lookup
Select an option...
HARP Harpoon Therapeutics Inc
VIRC Virco Mfg Corp
RVLP RVL Pharmaceuticals PLC
TRGP Targa Resources Corp
RCRT Recruiter.Com Group Inc
VGAS Verde Clean Fuels Inc
DHHC DiamondHead Holdings Corp
EJH E-Home Household Service Holdings Ltd
FLGC Flora Growth Corp
HL Hecla Mining Co
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in the developing a T cell engager that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. It is developing a pipeline of T cell engagers using its TriTACs, focused on the treatment of solid tumors and hematologic malignancies. It has also nominated its clinical candidate using its ProTriTAC platform, a prodrug version of its TriTAC platform, designed to expand the target space for T cell engagers and bring the benefits of TriTACs to the patients. The Company’s TriTAC product candidates include HPN328, HPN217 and HPN536. The Company’s ProTriTAC product candidate include HPN601. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells.

Closing Price
$0.6725
Day's Change
-0.0145 (-2.11%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.6997
Day's Low
0.631
Volume
(Average)
Volume:
344,365

10-day average volume:
328,263
344,365

U.S. Bancorp (NYSE: USB) Shareholder Alert: Investors May Have Potential Claims for Compensation - Rosca Scarlato Investor Lawyers

12:00 pm ET January 16, 2023 (PR Newswire) Print

Investor lawyers at the Rosca Scarlato law firm are investigating alleged securities violations, corporate misconduct, and misrepresentations, as well as questionable business practices involving U.S. Bancorp. (NYSE: USB) and/or its directors and officers, following the federal regulators' allegations that the bank opened unauthorized accounts and lines of credit for unsuspecting customers. The Rosca Scarlato attorneys are preparing to take action and seek compensation on behalf of injured USB investors.

U.S. Bancorp investors who invested in or before 2009 and are concerned about the recent USB stock price decline following the Consumer Financial Protection Bureau's ("CFPB") sanctions against U.S. Bank NA for alleged violations of consumer protection laws, and who would like to discuss potential claims for compensation may contact Alan Rosca at arosca@rscounsel.law, 888-998-0530, or by sending a message through the U.S. Bancorp Class Action Investigation page.

In late July 2022, USB's stock price fell sharply after US Bancorp's banking subsidiary US Bank, without admitting or denying the allegations, consented to a $37.5 million penalty for alleged unlawful acts or practices against consumers, including "opening credit cards, lines of credit, and deposit accounts without consumers' knowledge and consent."

U.S. Bancorp Investors May Be Able to Pursue Compensation Claims

Investor rights attorneys Alan Rosca and Paul Scarlato at Rosca Scarlato are evaluating potential claims for compensation on behalf of USB shareholders. They have decades of combined experience representing victims of corporate or financial misconduct.

If you are a U.S. Bancorp investor who invested in or before 2009 and are concerned about your investment and would like to learn more about potential options for compensation or redress, you may contact attorneys Rosca and Scarlato for a free evaluation of your potential claims.

The Rosca Scarlato attorneys typically take cases like this on a contingency fee basis, advance all case costs, and only get paid for their fees and expenses if and when they are successful, following review and approval by the Court of any fee application.

Visit https://investorlawyers.org for more information about the firm and the attorneys. You can also contact them directly at:

Rosca Scarlato LLC - 216-946-7070 / 888-998-0530Alan Rosca - arosca@rscounsel.lawPaul Scarlato - pscarlato@rscounsel.law

* This release may be deemed to include Attorney Advertising. There has been no finding of liability as to the allegations herein.

https://c212.net/c/img/favicon.png?sn=CG87415&sd=2023-01-16

View original content:https://www.prnewswire.com/news-releases/us-bancorp-nyse-usb-shareholder-alert-investors-may-have-potential-claims-for-compensation--rosca-scarlato-investor-lawyers-301722326.html

SOURCE Rosca Scarlato LLC

https://rt.newswire.ca/rt.gif?NewsItemId=CG87415&Transmission_Id=202301161200PR_NEWS_USPR_____CG87415&DateId=20230116

comtex tracking

COMTEX_422765856/1005/2023-01-16T12:00:09

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.